We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$6.48M
2
AMK
AssetMark Financial Holdings, Inc.
AMK
+$6.21M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$6.05M
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$5.93M
5
FTRE icon
Fortrea Holdings
FTRE
+$5.34M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$16.5M
2
NVDA icon
NVIDIA
NVDA
+$13.1M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.16M
4
VIPS icon
Vipshop
VIPS
+$8.72M
5
CSTR
CapStar Financial Holdings, Inc
CSTR
+$8.17M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IHS icon
1351
CALL
IHS Holding
IHS
$2.81B
– –
-78,000
Closed -$275K
NBP
1352
NovaBridge Biosciences American Depositary Shares
NBP
$202M
– –
-81,262
Closed -$151K
IMKTA icon
1353
Ingles Markets
IMKTA
$1.67B
– –
-3,304
Closed -$253K
INMD icon
1354
InMode
INMD
$880M
– –
-61,623
Closed -$1.33M
INSW icon
1355
International Seaways
INSW
$4.57B
– –
-4,101
Closed -$218K
INTT icon
1356
inTEST
INTT
$177M
– –
-15,175
Closed -$201K
INVH icon
1357
Invitation Homes
INVH
$18B
– –
-9,788
Closed -$349K
INZY
1358
DELISTED
Inozyme Pharma
INZY
– –
-62,445
Closed -$478K
IR icon
1359
Ingersoll Rand
IR
$33.7B
– –
-2,621
Closed -$249K
ITOS
1360
DELISTED
iTeos Therapeutics
ITOS
– –
-17,428
Closed -$238K
IWO icon
1361
iShares Russell 2000 Growth ETF
IWO
$15.1B
– –
-3,200
Closed -$867K
JCI icon
1362
Johnson Controls International
JCI
$92.2B
– –
-14,266
Closed -$932K
JRVR icon
1363
James River Group Holdings
JRVR
$217M
– –
-16,244
Closed -$151K
KBH icon
1364
KB Home
KBH
$3.59B
– –
-7,587
Closed -$538K
KMT icon
1365
Kennametal
KMT
$2.52B
– –
-17,565
Closed -$438K
KN icon
1366
Knowles
KN
$3.34B
– –
-12,930
Closed -$208K
KOP icon
1367
Koppers
KOP
$969M
– –
-8,086
Closed -$446K
KPTI icon
1368
Karyopharm Therapeutics
KPTI
$48M
– –
-1,567
Closed -$35.5K
KRC icon
1369
Kilroy Realty
KRC
$4.42B
– –
-6,709
Closed -$244K
KRYS icon
1370
Krystal Biotech
KRYS
$9.66B
– –
-3,403
Closed -$605K
KVUE icon
1371
Kenvue
KVUE
$36.9B
– –
-43,606
Closed -$936K
LBRT icon
1372
Liberty Energy
LBRT
$3.25B
– –
-17,308
Closed -$359K
LEN icon
1373
Lennar Class A
LEN
$21.2B
– –
-4,071
Closed -$678K
LEU icon
1374
Centrus Energy
LEU
$3.82B
– –
-8,493
Closed -$353K
LNN icon
1375
Lindsay Corp
LNN
$1.18B
– –
-2,763
Closed -$325K
53 54
55
56 57

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.